BioSyent Inc. (TSXV:RX)

BioSyent Revenue

BioSyent had revenue of 10.98M CAD in the quarter ending March 31, 2025, with 41.96% growth. This brings the company's revenue in the last twelve months to 38.28M, up 16.55% year-over-year. In the year 2024, BioSyent had annual revenue of 35.03M with 10.89% growth.

• Revenue (ttm): 38.28M
• Revenue Growth: +16.55%
• P/S Ratio: 3.47
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 132.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	35.03M	3.44M	10.89%
Dec 31, 2023	31.59M	3.67M	13.12%
Dec 31, 2022	27.93M	-693.03K	-2.42%
Dec 31, 2021	28.62M	6.29M	28.15%
Dec 31, 2020	22.33M	907.84K	4.24%